Xerox DocuPrint N4525, Руководство пользователя

Страница: 105 / 115

User Guide
91
Section 2 - Emergency and First Aid
Primary Route of Entry: Inhalation
Eyes: Flush with water for several minutes.
Skin: Wash with soap and water.
Inhalation: Remove from exposure.
Ingestion: Dilute stomach contents with several glasses of milk or water.
Symptoms of Overexposure: Minimal respiratory tract irritation may occur as
with exposure to large amounts of any non-toxic dust.
Medical Conditions Generally Aggravated by Exposure: None when used as
described by product literature.
Additional Information: None
Section 3 - Toxicology and Health Information
This material has been evaluated by Xerox Corporation. The toxicity data
noted below is based on the test results of similar toners.
Oral LD
50
: >5 g/kg (rats) practically non-toxic.
Dermal LD
50
: >5 g/kg (rabbits) practically non-toxic.
Inhalation LC
50
: >5 mg/l (rats, 4 hour exposure) practically non-toxic.
>20 mg/l (rats, calculated 1 hour exposure) non-poisonous, DOT.
Eye Irritation: Non-irritating.
Skin Sensitization: Not a sensitizer.
Skin Irritation: Not an irritant.
Human Patch: Non-irritating, non-sensitizing.
Mutagenicity: No mutagenicity detected in Ames Assay.
*
Carcinogens: None present.
*
Aquatic LC
50
: Not tested
TLV: 10 mg/m
3
(total dust)
PEL: 15 mg/m
3
(total dust) 5 mg/m
3
(respirable dust)
STEL: None Established
Ceiling: None Established
Xerox Exposure Limit: 2.5 mg/m
3
(total dust) 0.4 mg/m
3
(respirable dust)
*Based on actual test results for this material
Specifications